[HTML][HTML] Pathophysiology of COVID-19-associated acute kidney injury

M Legrand, S Bell, L Forni, M Joannidis… - Nature Reviews …, 2021 - nature.com
Although respiratory failure and hypoxaemia are the main manifestations of COVID-19,
kidney involvement is also common. Available evidence supports a number of potential …

Severe covid-19 pneumonia: pathogenesis and clinical management

AH Attaway, RG Scheraga, A Bhimraj, M Biehl… - bmj, 2021 - bmj.com
Severe covid-19 pneumonia has posed critical challenges for the research and medical
communities. Older age, male sex, and comorbidities increase the risk for severe disease …

Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry

RP Barbaro, G MacLaren, PS Boonstra, A Combes… - The Lancet, 2021 - thelancet.com
Background Over the course of the COVID-19 pandemic, the care of patients with COVID-19
has changed and the use of extracorporeal membrane oxygenation (ECMO) has increased …

[HTML][HTML] Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study

Intensive care medicine, 2021 - Springer
Purpose To describe acute respiratory distress syndrome (ARDS) severity, ventilation
management, and the outcomes of ICU patients with laboratory-confirmed COVID-19 and to …

[HTML][HTML] COVID-19-associated coagulopathy and disseminated intravascular coagulation

H Asakura, H Ogawa - International journal of hematology, 2021 - Springer
The pathology of coronavirus disease 2019 (COVID-19) is exacerbated by the progression
of thrombosis, and disseminated intravascular coagulation (DIC), and cytokine storms. The …

Extracorporeal membrane oxygenation for COVID-19: updated 2021 guidelines from the extracorporeal life support organization

J Badulak, MV Antonini, CM Stead… - Asaio …, 2021 - journals.lww.com
Disclaimer: This is an updated guideline from the Extracorporeal Life Support Organization
(ELSO) for the role of extracorporeal membrane oxygenation (ECMO) for patients with …

[HTML][HTML] Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis

K Ramanathan, K Shekar, RR Ling, RP Barbaro… - Critical care, 2021 - Springer
Background There are several reports of extracorporeal membrane oxygenation (ECMO)
use in patients with coronavirus disease 2019 (COVID-19) who develop severe acute …

[HTML][HTML] ECMO for severe ARDS: systematic review and individual patient data meta-analysis

A Combes, GJ Peek, D Hajage, P Hardy… - Intensive care …, 2020 - Springer
Purpose To assess the effect of venovenous extracorporeal membrane oxygenation (ECMO)
compared to conventional management in patients with severe acute respiratory distress …

[HTML][HTML] Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis

X Li, C Liu, Z Mao, M Xiao, L Wang, S Qi, F Zhou - Critical Care, 2020 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19), a highly infectious disease,
has been rapidly spreading all over the world and remains a great threat to global public …

Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort …

G Lebreton, M Schmidt, M Ponnaiah… - The Lancet …, 2021 - thelancet.com
Background In the Île-de-France region (henceforth termed Greater Paris), extracorporeal
membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) was …